A detailed history of Core Cap Advisors, LLC transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Core Cap Advisors, LLC holds 53 shares of ARKG stock, worth $1,230. This represents 0.0% of its overall portfolio holdings.

Number of Shares
53
Previous 53 -0.0%
Holding current value
$1,230
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$23.01 - $28.35 $1,219 - $1,502
53 New
53 $1,000
Q1 2024

Aug 08, 2024

BUY
$27.9 - $32.96 $1,422 - $1,680
51 Added 96.23%
104 $2,000
Q4 2022

Feb 10, 2023

BUY
$27.08 - $36.23 $3,249 - $4,347
120 New
120 $3,000
Q2 2022

Aug 11, 2022

BUY
$27.2 - $48.94 $6,854 - $12,332
252 New
252 $8,000
Q1 2022

Apr 29, 2022

SELL
$38.15 - $63.26 $9,613 - $15,941
-252 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$58.39 - $78.64 $14,714 - $19,817
252 New
252 $15,000

Others Institutions Holding ARKG

About ARK GENOMIC REVOLUTION ETF (DE


  • Ticker ARKG
  • Sector ETFs
  • Industry ETFs
More about ARKG
Track This Portfolio

Track Core Cap Advisors, LLC Portfolio

Follow Core Cap Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Core Cap Advisors, LLC with notifications on news.